A meta-analysis of confocal laser endomicroscopy for the detection of neoplasia in patients with Barrett's esophagus

Journal of Gastroenterology and Hepatology (Australia)

Volumn 31, Issue 6, 2016, Pages 1102-1110

  Xiong, Yi Quan ^a   Ma, Shu Juan ^a   Zhou, Jun Hua ^b   Zhong, Xue Shan ^a   Chen, Qing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Barrett's esophagus; Confocal laser endomicroscopy; Meta analysis; Neoplasia

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; COCHRANE LIBRARY; CONFOCAL LASER MICROSCOPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EMBASE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS DYSPLASIA; HIGH GRADE DYSPLASIA; HISTOPATHOLOGY; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; WEB OF SCIENCE; ADENOCARCINOMA; AGED; AREA UNDER THE CURVE; CHI SQUARE DISTRIBUTION; CONFOCAL MICROSCOPY; DIFFERENTIAL DIAGNOSIS; EARLY CANCER DIAGNOSIS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; MALE; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; STATISTICAL MODEL;

ADENOCARCINOMA; AGED; AREA UNDER CURVE; BARRETT ESOPHAGUS; CHI-SQUARE DISTRIBUTION; DIAGNOSIS, DIFFERENTIAL; EARLY DETECTION OF CANCER; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 84971265254     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.13267     Document Type: Article

References (41)

1. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J. Natl. Cancer Inst. 2005; 97: 142-6.
2. Stein HJ, Siewert JR. Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management. Dysphagia 1993; 8: 276-88.
3. Sharma P, McQuaid K, Dent J et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 2004; 127: 310-30.
4. Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 2004; 53: 1070-4.
5. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am. J. Gastroenterol. 2002; 97: 1888-95.
6. Hirota WK, Zuckerman MJ, Adler DG et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest. Endosc. 2006; 63: 570-80.
7. Wang KK, Sampliner RE. Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am. J. Gastroenterol. 2008; 103: 788-97.
8. Harrison R, Perry I, Haddadin W, McDonald S, Bryan R, Abrams K. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am. J. Gastroenterol. 2007; 102: 1154-61.
9. Egger K, Werner M, Meining A et al. Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut 2003; 52: 18-23.
10. Peters FP, Curvers WL, Rosmolen WD et al. Surveillance history of endoscopically treated patients with early Barrett's neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error. Dis. Esophagus 2008; 21: 475-9.
11. Abela JE, Going JJ, Mackenzie JF, McKernan M, O'Mahoney S, Stuart RC. Systematic fourquadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy. Am. J. Gastroenterol. 2008; 103: 850-5.
12. Kariv R1, Plesec TP, Goldblum JR et al. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin. Gastroenterol. Hepatol. 2009; 7: 653-8.
13. Kiesslich R, Burg J, Vieth M et al. Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. Gastroenterology 2004; 127: 706-13.
14. Leggett CL, Gorospe EC. Application of confocal laser endomicroscopy in the diagnosis and management of Barrett's esophagus. Ann. Gastroenterol. 2014; 27: 193-9.
15. Cinotti E, Perrot JL, Labeille B et al. Handheld reflectance confocal microscopy for the diagnosis of conjunctival tumors. Am. J. Ophthalmol. 2015; 159: 324-33.e1.
16. El Hallani S, Poh CF, Macaulay CE, Follen M, Guillaud M, Lane P. Ex vivo confocal imaging with contrast agents for the detection of oral potentially malignant lesions. Oral Oncol. 2013; 49: 582-90.
17. Gerger A, Koller S, Weger W et al. Sensitivity and specificity of confocal laser-scanning microscopy for in vivo diagnosis of malignant skin tumors. Cancer 2006; 107: 193-200.
18. Hurlstone DP, Baraza W, Brown S, Thomson M, Tiffin N, Cross SS. In vivo real-time confocal laser scanning endomicroscopic colonoscopy for the detection and characterization of colorectal neoplasia. Br. J. Surg. 2008; 95: 636-45.
19. Kiesslich R, Gossner L, Goetz M et al. In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy. Clin. Gastroenterol. Hepatol. 2006; 4: 979-87.
20. Jayasekera C, Taylor AC, Desmond PV, Macrae F, Williams R. Added value of narrow band imaging and confocal laser endomicroscopy in detecting Barrett's esophagus neoplasia. Endoscopy 2012; 44: 1089-95.
21. Wu J, Pan YM, Wang TT, Hu B. Confocal laser endomicroscopy for detection of neoplasia in Barrett's esophagus: a meta-analysis. Dis. Esophagus 2014; 27: 248-54.
22. Gupta A, Attar BM, Koduru P, Murali AR, Go BT, Agarwal R. Utility of confocal laser endomicroscopy in identifying high-grade dysplasia and adenocarcinoma in Barrett's esophagus: a systematic review and meta-analysis. Eur. J. Gastroenterol. Hepatol. 2014; 26: 369-77.
23. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6: e1000097.
24. Whiting PF, Rutjes AW, Westwood ME. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med. 2011; 155: 529-36.
25. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat. Med. 1993; 12: 1293-316.
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986; 7: 177-88.
27. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med. Res. Methodol. 2006; 6: 31.
28. Sharma P, Meining AR, Coron E et al. Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest. Endosc. 2011; 74: 465-72.
29. Becker V, Vieth M, Bajbouj M, Schmid RM, Meining A. Confocal laser scanning fluorescence microscopy for in vivo determination of microvessel density in Barrett's esophagus. Endoscopy 2008; 40: 888-91.
30. Bertani H, Frazzoni M, Dabizzi E et al. Improved detection of incident dysplasia by probe-based confocal laser endomicroscopy in a Barrett's esophagus surveillance program. Dig. Dis. Sci. 2013; 58: 188-93.
31. Pohl H, Rosch T, Vieth M et al. Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus. Gut 2008; 57: 1648-53.
32. Wallace MB, Crook JE, Saunders M et al. Multicenter, randomized, controlled trial of confocal laser endomicroscopy assessment of residual metaplasia after mucosal ablation or resection of GI neoplasia in Barrett's esophagus. Gastrointest. Endosc. 2012; 76: 539-47 e1.
33. Gaddam S, Mathur SC, Singh M et al. Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in barrett's esophagus. Am. J. Gastroenterol. 2011; 106: 1961-9.
34. Thekkek N, Maru DM, Polydorides AD, Bhutani MS, Anandasabapathy S, Richards-Kortum R. Pre-clinical evaluation of fluorescent deoxyglucose as a topical contrast agent for the detection of Barrett's-associated neoplasia during confocal imaging. Tech. Cancer Res. Treat. 2011; 10: 431-41.
35. Bajbouj M, Vieth M, Rösch T et al. Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barrett's esophagus. Endoscopy 2010; 42: 435-40.
36. Trovato C, Sonzogni A, Ravizza D et al. Confocal laser endomicroscopy for in vivo diagnosis of Barrett's oesophagus and associated neoplasia: A pilot study conducted in a single Italian centre. Dig. Liver Dis. 2013; 45: 396-402.
37. Dunbar KB, Canto MI. Confocal laser endomicroscopy in Barrett's esophagus and endoscopically inapparent Barrett's neoplasia: A prospective, randomized, double-blind, controlled, crossover trial. Gastrointest. Endosc. 2010; 72: 668.
38. Konda VJ, Chennat JS, Hart J, Waxman I. Confocal laser endomicroscopy: potential in the management of Barrett's esophagus. Dis. Esophagus 2010; 23: E21-31.
39. Canto MI, Anandasabapathy S, Brugge W et al. In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia: a multicenter international randomized controlled trial (with video). Gastrointest. Endosc. 2014; 79: 211-21.
40. Wanders LK, East JE, Uitentuis SE, Leeflang MM, Dekker E. Diagnostic performance of narrowed spectrum endoscopy, autofluorescence imaging, and confocal laser endomicroscopy for optical diagnosis of colonic polyps: a meta-analysis. Lancet Oncol. 2013; 14: 1337-47.
41. Wang KK, Sampliner RE. Updated Guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am. J. Gastroenterol. 2008; 103: 788-97.